The open-market selling is minor relative to company size and appears related to personal tax and liquidity management following equity vesting. No red flags in fundamentals, but traders should monitor for any pattern of increasing insider selling in future filings.
How the stock moved after the report
⚠ Clustered NEUTRAL VIEWSTOCK ABOVE ENTRY AT T+60- T+0 · Mar 17 $540.02entry
- T+1 · 8mo ago −1.79%α −0.40% · $530.35
- T+5 · 8mo ago −1.52%α +1.11% · $531.82
- T+20 · 7mo ago +6.96%α +2.61% · $577.58
- T+60 · 5mo ago +1.00%α −8.99% · $545.40
Price Chart
REPLAYWatch the reaction play outHow similar events traded
Executive Summary
United Therapeutics CEO Martine Rothblatt and other insiders engaged in a series of derivative exercises and open-market sales over the past week, with total open-market sales by insiders amounting to approximately $1.28 million. The majority of the activity consists of non-cash transactions (derivative exercises and tax withholdings), including a large tax-related share surrender worth $7.3 million by the CEO. The open-market selling was modest in dollar terms relative to the company's $23.1B market cap.
Key Financial Metrics
Key Facts
- CEO Martine Rothblatt sold 1,657 shares in open-market transactions totaling ~$1.07 million at prices between $522.88 and $534.99.
- EVP Paul Mahon sold 753 shares in open market for ~$397K.
- Director Malcolm Jan sold 45 shares for ~$24K; Director Judy Olian sold 200 shares for ~$107K.
- CEO and EVP exercised derivatives totaling 9,500 and 8,300 shares respectively on multiple dates, with exercise prices of $146.03 and $0.
- CEO surrendered 13,637 shares for tax withholding purposes (~$7.3M value); EVP surrendered 4,457 shares (~$2.39M).
- Total open-market sales by insiders in the cluster: ~$1.28 million.
- Total value of non-cash transactions (M, A, F): ~$12.7 million.
Financial Impact
$1.28 million in open-market selling over 7 days, representing 0.0055% of market cap
Risk Factors
- Perception of insider profit-taking, though at a very small scale
- Large tax withholdings could signal significant vesting events, which may recur
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 1 SEC document filed with EDGAR.
| Document | Accession Number |
|---|---|
| CONTEXT: Insider Cluster Data (20 trades, 7d window) | cluster-UTHR-1774038735009 |
Track record
123 reports on UTHR
4 of 9 bullish or bearish reports moved the stock their way by T+5. Best: +10.30% at T+20 after the Oct 14, 2026 report. 5 of 9 went positive at some point.
Filters
- Nov 16, 2026today Insider Cluster Neutral 3/10 Entry price pending
- Nov 13, 20263d ago Insider Cluster Bearish 4/10 Entry $597.50 Now $587.88 +1.61% settles Nov 23
- Nov 12, 20264d ago Insider Cluster Neutral 2/10 Entry $591.17 Now $587.88 −0.56% settles Nov 20
- Nov 10, 20266d ago Insider Cluster Neutral 2/10 Entry $595.66 Now $587.88 −1.31% settles Nov 18
- Nov 9, 20267d ago Insider Cluster Neutral 2/10 Entry $588.61 Now $587.88 −0.12% settles Nov 17
- Nov 9, 20267d ago 144 Neutral 2/10 Entry $588.61 Now $587.88 −0.12% settles Nov 17
- Nov 6, 202610d ago Insider Cluster Neutral 2/10 Entry $582.46 to $587.88 Now $587.88 +0.93% ▲ +0.93% +2.62% vs SPY
- Nov 5, 202611d ago Insider Cluster Neutral 2/10 Entry $562.02 to $591.17 Now $587.88 +4.60% ▲ +5.19% +2.59% vs SPY
- Nov 5, 202611d ago 144 Neutral 2/10 Entry $562.02 to $591.17 Now $587.88 +4.60% ▲ +5.19% +2.59% vs SPY
- Nov 4, 202612d ago SC 13G/A Neutral 2/10 Entry $565.72 to $593.31 Now $587.88 +3.92% ▲ +4.88% +1.59% vs SPY
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers